Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NNZ-2566 in Adolescents and Adults With Mild Traumatic Brain Injury
NCT02100150Phase 2Terminated
- Sponsor
- Neuren Pharmaceuticals Limited
- Start
- Sep 2014
- Primary completion
- Jun 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trofinetide in traumatic brain injury (TBI), sponsored by Neuren Pharmaceuticals Limited. Started Sep 2014; status: terminated.
02
Drugs
trofinetide
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02100150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100150.